Zimmer Biomet Announces Second Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Zimmer Biomet (ZBH) PT Lowered to $130 at Stifel
August 7, 2024 2:03 PM EDTStifel analyst Rick Wise lowered the price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $135.00) while maintaining a Buy rating.
The analyst comments "We left Zimmer's 2Q24 earnings call better-appreciating the many fundamental positives and sales growth drivers. We were reminded that over... More



